Abstract
Receptor tyrosine kinases (RTKs) are cell surface receptors that transmit extracellular signals to the interior of the cell activating multiple signaling cascades: the binding of specific extracellular ligands activates RTKs which act as a scaffold at plasma membrane level for the recruitment and activation of several signaling molecules. A paradigm shift emerged when an alternative direct signaling pathway was discovered: RTKs may move from cell surface to nucleus where they transduce the signals in a direct way. More recently, evidence has accumulated that RTKs may also translocate to mitochondria and regulate their functions, i.e., by altering tyrosine phosphorylation of specific mitochondrial proteins. This latter emerging pathway is here reviewed and discussed.
Keywords: EGFR, ErbB-2, FGFR-1, FLT-3, mitochondria, neurotrophin receptors, tyrosine kinase receptors, tyrosine phosphorylation.
Current Protein & Peptide Science
Title:Receptor Tyrosine Kinases Take a Direct Route to Mitochondria: An Overview
Volume: 14 Issue: 7
Author(s): Mauro Salvi
Affiliation:
Keywords: EGFR, ErbB-2, FGFR-1, FLT-3, mitochondria, neurotrophin receptors, tyrosine kinase receptors, tyrosine phosphorylation.
Abstract: Receptor tyrosine kinases (RTKs) are cell surface receptors that transmit extracellular signals to the interior of the cell activating multiple signaling cascades: the binding of specific extracellular ligands activates RTKs which act as a scaffold at plasma membrane level for the recruitment and activation of several signaling molecules. A paradigm shift emerged when an alternative direct signaling pathway was discovered: RTKs may move from cell surface to nucleus where they transduce the signals in a direct way. More recently, evidence has accumulated that RTKs may also translocate to mitochondria and regulate their functions, i.e., by altering tyrosine phosphorylation of specific mitochondrial proteins. This latter emerging pathway is here reviewed and discussed.
Export Options
About this article
Cite this article as:
Salvi Mauro, Receptor Tyrosine Kinases Take a Direct Route to Mitochondria: An Overview, Current Protein & Peptide Science 2013; 14 (7) . https://dx.doi.org/10.2174/13892037113146660087
DOI https://dx.doi.org/10.2174/13892037113146660087 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Boron Containing Macromolecules and Nanovehicles as Delivery Agents for Neutron Capture Therapy†
Anti-Cancer Agents in Medicinal Chemistry Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals
Recent Patents on Anti-Cancer Drug Discovery Molecular Imaging of Brain Tumors Personal Experience and Review of the Literature
Current Molecular Medicine Drug Tissue Distribution: Study Methods and Therapeutic Implications
Current Pharmaceutical Design Targeting Focal Adhesion Kinase in Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets Mutations in MicroRNA Genes and Their Binding Sites are Infrequently Associated with Human Colorectal Cancer in the Kashmiri Population
MicroRNA From TGF-β to Cancer Therapy
Current Drug Targets Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
Current Medicinal Chemistry Diffusion-Weighted MRI for Assessment of Early Cancer Treatment Response
Current Pharmaceutical Biotechnology Therapeutic Potential of Group III Metabotropic Glutamate Receptors
Current Medicinal Chemistry Synergistic Effect of Immunotherapy and Chemotherapy in Cancers: Perspective in High Grade Glioma Treatment
Letters in Drug Design & Discovery C-11 Radiochemistry in Cancer Imaging Applications
Current Topics in Medicinal Chemistry Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma
Current Cancer Therapy Reviews Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier
Current Drug Metabolism Amyotrophic Lateral Sclerosis: From Research to Therapeutic Attempts and Therapeutic Perspectives
Current Medicinal Chemistry Molecular and Cellular Regulators of Cancer Angiogenesis
Current Cancer Drug Targets Targeting the EGFR-family for Therapy: Biological Challenges and Clinical Perspective
Current Pharmaceutical Design Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
Current Pharmaceutical Design